| Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study KE Mansfield, R Mathur, J Tazare, AD Henderson, AR Mulick, H Carreira, ... The Lancet Digital Health 3 (4), e217-e230, 2021 | 295 | 2021 |
| Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February DJ Grint, K Wing, E Williamson, HI McDonald, K Bhaskaran, D Evans, ... Eurosurveillance 26 (11), 2100256, 2021 | 220 | 2021 |
| Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis E Kilich, S Dada, MR Francis, J Tazare, RM Chico, P Paterson, HJ Larson PloS one 15 (7), e0234827, 2020 | 148 | 2020 |
| Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform EJ Williamson, HI McDonald, K Bhaskaran, AJ Walker, S Bacon, S Davy, ... bmj 374, 2021 | 110 | 2021 |
| Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY AJ Walker, B MacKenna, P Inglesby, L Tomlinson, CT Rentsch, HJ Curtis, ... British Journal of General Practice 71 (712), e806-e814, 2021 | 96 | 2021 |
| Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform B MacKenna, NA Kennedy, A Mehrkar, A Rowan, J Galloway, ... The Lancet Rheumatology 4 (7), e490-e506, 2022 | 93 | 2022 |
| Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England DJ Grint, K Wing, C Houlihan, HP Gibbs, SJW Evans, E Williamson, ... Clinical Infectious Diseases 75 (1), e1120-e1127, 2022 | 88 | 2022 |
| Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY … B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher, L Nab, A Schultze, ... bmj 379, 2022 | 68 | 2022 |
| Survival outcomes and prognostic factors in glioblastoma NF Brown, D Ottaviani, J Tazare, J Gregson, N Kitchen, S Brandner, ... Cancers 14 (13), 3161, 2022 | 62 | 2022 |
| Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65 A Schultze, E Nightingale, D Evans, W Hulme, A Rosello, C Bates, ... The Lancet Regional Health–Europe 14, 2022 | 50 | 2022 |
| OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England C Andrews, A Schultze, H Curtis, W Hulme, J Tazare, S Evans, A Mehrkar, ... Wellcome Open Research 7, 2022 | 45 | 2022 |
| Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform OpenSAFELY Collaborative, J Tazare, AJ Walker, L Tomlinson, ... MedRxiv, 2021.01. 22.21250304, 2021 | 29 | 2021 |
| Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY OpenSAFELY Collaborative, A Green, H Curtis, W Hulme, E Williamson, ... BMC medicine 20 (1), 243, 2022 | 25 | 2022 |
| Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform JL Walker, A Schultze, J Tazare, A Tamborska, B Singh, K Donegan, ... Vaccine 40 (32), 4479-4487, 2022 | 22 | 2022 |
| Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY WJ Hulme, EJ Williamson, ACA Green, K Bhaskaran, HI McDonald, ... bmj 378, 2022 | 21 | 2022 |
| Proton pump inhibitors and risk of all‐cause and cause‐specific mortality: A cohort study JP Brown, JR Tazare, E Williamson, KE Mansfield, SJ Evans, ... British journal of clinical pharmacology 87 (8), 3150-3161, 2021 | 18 | 2021 |
| Identifying care home residents in electronic health records-an OpenSAFELY short data report A Schultze, C Bates, J Cockburn, B MacKenna, E Nightingale, HJ Curtis, ... Wellcome open research 6, 2021 | 18 | 2021 |
| Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective … ACA Green, HJ Curtis, R Higgins, L Nab, V Mahalingasivam, RM Smith, ... BMJ medicine 2 (1), 2023 | 16 | 2023 |
| Transparency of high‐dimensional propensity score analyses: guidance for diagnostics and reporting J Tazare, R Wyss, JM Franklin, L Smeeth, SJW Evans, SV Wang, ... Pharmacoepidemiology and Drug Safety 31 (4), 411-423, 2022 | 14 | 2022 |
| Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using … B Zheng, J Tazare, L Nab, A Mehrkar, B MacKenna, B Goldacre, ... medRxiv, 2023.01. 20.23284849, 2023 | 12 | 2023 |
